Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
Trashing Free Trade: The Basel Convention’s Impact on International Commerce
Trashing Free Trade: The Basel Convention’s Impact on International Commerce by James M. Sheehan With the establishment of the World Trade Organization (WTO) in 1995,…
Study
Cardiac and Cancer Specialists on the Need for FDA Reform
Two National Polls Debunk The Notion That FDA Doesn't Need Fixing…
News Release
Listen to CEI’s Radio and TV ads on Drug Lag–the delayed availability of new therapies due to FDA regulation
CEI’s radio ad on FDA’s drug approval system, Ocean Storm, is available at: http://cei.org/sites/default/files/CEI_Radio_Storm.mp3 CEI’s television ad is available at:…
Study
Breaking The FDA’s Drug Approval Monopoly:
Executive Summary The Food and Drug Administration’s monopoly over approving new medical therapies is premised on the idea that information markets fail. In…
Op-Eds
Nailed by FDA
I started 1996 with two new experiences. I had a close-up photograph taken of my big toe, and I had my first personal run-in with…
Products
Rachel Was Wrong
Rachel Carson's Silent Spring ushered in an era of national concern over the potential effects of synthetic chemicals. Published in 1962, Carson's book suggested that…